Mage Biologics Inc.
PrivateLast Round
Corporate Funding
Jul 20, 2023
Total Funding Raised
$28M
Company Overview
Mage Biologics Inc. is a biotechnology company that develops orally administered monoclonal antibodies for the treatment of inflammatory bowel diseases such as ulcerative colitis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mage Biologics Inc. Comparables
Compare Mage Biologics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sorriso Therapeutics | 84% | |
| Cyclo Therapeutics Inc | 74% | |
| Bristol Myers Squibb | 72% |
Mage Biologics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Jul 20, 2023 |
Mage Biologics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TVM Capital | Corporate Funding |
Mage Biologics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Mage Biologics Inc.'s valuation, stock price, and market status.
Is Mage Biologics Inc. a public or private company?
Mage Biologics Inc. is a private company.
What is the current stock price of Mage Biologics Inc.?
Mage Biologics Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Mage Biologics Inc. worth (valuation)?
Valuation information for Mage Biologics Inc. is not publicly available.
Can I buy Mage Biologics Inc. stock?
Mage Biologics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Mage Biologics Inc.'s last funding round?
Mage Biologics Inc.'s most recent funding round was Corporate Funding on July 20, 2023.
Who are the main investors in Mage Biologics Inc.?
Key investors in Mage Biologics Inc. include TVM Capital.
Will Mage Biologics Inc. IPO soon?
No public IPO plans have been announced for Mage Biologics Inc..
How can I track Mage Biologics Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mage Biologics Inc.'s secondary market activity and sign up for updates.